Yona Keisari

4.8k citations
116 papers · 4.0k indexed · 2 hit papers · h-index 32

Yona Keisari

113 papers receiving 3.9k citations

Hit Papers

Superoxide anion and hydrogen peroxide production by chem...44819802026199520102505007501000

Peers

Yona Keisari
Comparison fields: 5 of 133
  • Immunology 890
  • Molecular Medicine 190
  • Endocrinology 186
  • Radiation 260
  • Pulmonary and Respiratory Medicine 745
Replace Mei Hong with:
Mei Hong China
W.S. Fred Wong Singapore
Shrikant Anant United States
Shiro Kanegasaki Japan
Mark P. Molloy Australia
Kazuo Kobayashi Japan
D. Mark Pritchard United Kingdom
Gerald D. Abrams United States
Carmen Berasain Spain
Alastair J.M. Watson United Kingdom
Yona Keisari relative to Mei Hong China Mei Hong's profile →
Citations per field
00.5×5.4×
Mei Hong · 1×
Citations per year

Countries citing papers authored by Yona Keisari

Since Specialization
Citations

This map shows the geographic impact of Yona Keisari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yona Keisari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yona Keisari more than expected).

Fields of papers citing papers by Yona Keisari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yona Keisari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yona Keisari. The network helps show where Yona Keisari may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yona Keisari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yona Keisari Line = papers co-authored together Yona Keisari links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20231
3 20225
4 202024
5 201944
6 201939
7 201636
8 201644
9
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.
200933
10 200817
11 200777
12 200318
13 19994
14 19963
15 19932
16 19931
17 199253
18 19903
19 19899
20 198712

About Yona Keisari

Yona Keisari is a scholar working on Endocrinology, Immunology and Radiation, having authored 116 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Radiation Therapy and Dosimetry (13 papers), Immune Response and Inflammation (12 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Advanced Radiotherapy Techniques (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Nanoplatforms for cancer theranostics (9 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Immunology (890 citations), Molecular Medicine (190 citations) and Endocrinology (186 citations). Yona Keisari has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Edgar Pick, I. Kelson, Michael Schmidt, Nathan Sharon, Itzhak Ofek, I. Ofek, L. Arazi, Tomer Cooks, Janina Goldhar and Eliezer Flescher. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026